2-[(3-phenoxyphenyl)methyl]-3,4-dihydro-1H-isoquinoline

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异喹啉及其衍生物
• 英文名称: 2-[(3-phenoxyphenyl)methyl]-3,4-dihydro-1H-isoquinoline
• 化学式: C₂₂H₂₁NO
• 分子量: 315.4
• InChiKey: HHIAYBJWTPMSIB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.8
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.18
• 拓扑面积：
  12.5
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• Compounds, pharmaceutical compositions and methods of use therefor
  申请人：Ghosh Shomir

  公开号：US20050143372A1

  公开（公告）日：2005-06-30

  The invention relates to compounds having the formula (I). Preferred compounds are antagonists of C—C chemokine receptor 8. The invention also relates to a method for treating a subjected having an inflammatory disorder or viral disorder comprising administering to a subject in need thereof an effective amount of a compound of the invention.

  该发明涉及具有公式（I）的化合物。首选化合物是C-C趋化因子受体8的拮抗剂。该发明还涉及一种治疗患有炎症性疾病或病毒性疾病的受试者的方法，该方法包括向需要的受试者施用该发明的化合物的有效量。
• [EN] COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREFOR<br/>[FR] COMPOSES, COMPOSITIONS PHARMACEUTIQUES ET METHODES D'UTILISATION
  申请人：MILLENNIUM PHARM INC

  公开号：WO2003037271A2

  公开（公告）日：2003-05-08

  The invention relates to compounds having the formula (I). Preferred compounds are antagonists of C-C chemokine receptor 8. The invention also relates to a method for treating a subjected having an inflammatory disorder or viral disorder comprising administering to a subject in need thereof an effective amount of a compound of the invention.
• [EN] FUNCTION OF CHEMOKINE RECEPTOR CCR8 IN MELANOMA METASTASIS<br/>[FR] FONCTION DU RÉCEPTEUR DE CHIMIOKINE CCR8 DANS DES MÉTASTASES DE MÉLANOME
  申请人：ICAHN SCHOOL MED MOUNT SINAI

  公开号：WO2013131010A2

  公开（公告）日：2013-09-06

  This invention provides a method of treating a subject who has, or has been treated for, a solid tumor which comprises administering to the subject an antagonist of CCR8 receptors on the surface of tumor cells present in the solid tumor in an amount effective to reduce binding of CCL1 to the CCR8 receptors so as to thereby treat the subject. This invention also provides a method of reducing, or reducing the likelihood of, metastases in a subject who has, or has been treated for, a solid tumor which comprises administering to the subject an antagonist of CCR8 receptors on the surface of tumor cells present in the solid tumor in an amount effective to reduce binding of CCL1 to the CCR8 receptors so as to thereby reduce, or reduce the likelihood of, metastases in the subject.